HealthcareConsip Taps DXC Technology to Digitally Transform Italian National Healthcare Sector

DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, has signed a framework agreement with Consip to digitally transform the Italian public healthcare sector.

Consip is the procurement arm of the Italian Ministry of Economy and Finance (MEF). It operates as Italy’s central purchasing body, supporting government organizations in their procurement activities and helping to direct complex and innovative transformation projects.

As part of the agreement, DXC will modernize Italy’s public healthcare information systems to maximize data analytics capabilities. Deploying innovative and advanced analytics solutions, including artificial intelligence, national healthcare organizations will be able to efficiently manage citizen and patient data, improving their experiences and delivering greater value for public services.

“The public healthcare sector has an ever-growing volume of data, applications and systems that need to be carefully managed,” said Nicola Mangia, Italy Public Sector General Manager at DXC Technology. “We are helping to develop new models of healthcare services and infrastructure. These will synergize the public and private healthcare sectors and emphasize citizen experiences at the heart of the solution.”

The Consip Framework Agreement is part of the Italian Government’s National Recovery and Resilience Plan (PNRR) to accelerate the digitization of public sector services to maximize value for Italian citizens.

“The healthcare sector is very important in Italy, and technological innovation will fundamentally contribute to better healthcare services and improved user experiences capable of revolutionizing a citizen’s quality of life,” continued Mangia. “We’re really proud to be at the center of such an important transformation for our country’s infrastructure, as being part of the PNRR represents a unique opportunity to positively contribute to the lives of so many citizens.”

Forward Looking Statements

All statements in this press release that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. For a written description of these factors, see the section titled “Risk Factors” in DXC’s upcoming Annual Report on Form 10-K for the fiscal year ended March 31, 2023, and any updating information in subsequent SEC filings. No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this report or to reflect the occurrence of unanticipated events except as required by law.


Leave a Reply

Your email address will not be published. Required fields are marked *